Printer Friendly Version View printer-friendly version
<< Back
Kite Pharma to Present at the Citi 9th Annual Biotech Conference on Wednesday, September 3
Download PDF Download PDF

Kite Pharma to Present at the Citi 9th Annual Biotech Conference on Wednesday, September 3

SANTA MONICA, Calif., Aug. 26, 2014 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Kite) (Nasdaq:KITE), a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy (eACT™) products for the treatment of cancer, today announced its participation at Citi's 9th Annual Biotech Conference at the Mandarin Oriental in Boston on Wednesday, September 3rd, at 6:00pm ET. Arie Belldegrun, M.D., FACS, President and Chief Executive Officer, will discuss Kite's development efforts on a panel titled, "How CAR-T Cell Therapies are Shaping Oncology's Future."

About Kite Pharma, Inc.

Kite Pharma, Inc. is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on eACT™ designed to restore the immune system's ability to recognize and eradicate tumors. In partnership with the NCI Surgery Branch through a Cooperative Research and Development Agreement (CRADA), Kite is advancing a pipeline of proprietary eACT™ product candidates, both CAR (chimeric antigen receptor) and TCR (T cell receptor) products, directed to a wide range of cancer indications. Kite's management team has a proven track record of building successful biotechnology companies and successfully developing novel immunotherapies and other oncology treatments. Kite is based in Santa Monica, CA.

CONTACT: Kite Pharma

         Cynthia M. Butitta

         Chief Financial Officer and Chief Operating Officer

         310-824-9999

         

         For Media: Justin Jackson

         For Investor Inquiries: Kimberly Minarovich

         Burns McClellan

         212-213-0006

         jjackson@burnsmc.com

         kminarovich@burnsmc.com
NASDAQ (US Dollar)
$72.46
 Stock is Down 0.36 (0.49%)
Data as of 11/24/17 1:15 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts
Gilead Sciences at Morgan Stanley Global Healthcare Conference

September 11, 2017 9:55 a.m. ET
Play
Gilead Sciences at Citi’s 12th Annual Biotech Conference

September 06, 2017 11:00 a.m. ET
Play
Gilead Sciences Business Update

August 28, 2017 8:00 a.m. ET
Play